Navigation Links
NeoStem to Present at 13th Annual BIO CEO & Investor Conference
Date:2/10/2011

ure investment landscape of the biotechnology industry. For more information on the conference, visit http://www.bio.org/bioceo. For the latest biotech data analysis and insights from BIO Industry Analysis, visit http://insidebioia.com/.

Forward-Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements reflect management's current expectations, as of the date of this press release, and involve certain risks and uncertainties. Forward looking statements include statements herein with respect to the ability of PCT's business to complement NeoStem's adult stem cell operations and successful execution of the Company's strategy, as well as other advances in the Company's business, about which no assurances can be given. The Company's actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors. Factors that could cause future results to materially differ from the recent results or those projected in forward-looking statements include the "Risk Factors" described in the Company's Annual Report on Form 10-K filed with the Securities and Exchange Commission on March 31, 2010, its Form S-4/A filed with the Securities and Exchange Commission on December 3, 2010 as well as other periodic filings made with the Securities and Exchange Commission. The Company's further development is highly dependent on future medical and research developments and market acceptance, which is outside its control. NeoStem may experience difficulties in integrating PCT's business and could fail to realize potential benefits of the merger. Acquisitions may entail numerous risks for NeoStem, including difficulties in assimilating acquired operations, technologies or products, including the loss of key employees from acquired busines
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. $1,700,000 Funding of NeoStems Very Small Embryonic-Like Stem Cells Being Developed to Treat Osteoporosis Recommended by the Department of Defense Peer Reviewed Medical Research Program
2. NeoStem to Present at Two Investor Conferences in San Francisco on Wednesday, January 12, 2011
3. NeoStem Announces Agreement With Shijiazhuang Third Hospital in the Provincial Capital of Hebei Province, China to Offer Orthopedic Applications Based on NeoStem’s Licensed Technology
4. NeoStem to Present at Two Investor Conferences Thursday, November 18, 2010
5. NeoStem Announces Pricing of Concurrent Offerings for $19 Million in Gross Proceeds
6. NeoStem Provides Third Quarter Update
7. NeoStem to Present at LifeTech Capital Miami Medical Investors Conference
8. Local Chinese Government Authorities Approve Pricing and Reimbursement for NeoStems Licensed Adult Stem Cell Treatments for Orthopedic Applications in China
9. NeoStem to Present at Cell Therapy Industry Summit to be held on November 3-5, 2010 in Carlsbad, California
10. NeoStem and Progenitor Cell Therapy Announce Entry Into Merger Agreement
11. NeoStem Comments on Recent Court Ruling Blocking the Federal Governments Funding of Embryonic Stem Cell Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/26/2015)... Research and Markets ( ... "Global Smart Wearable Healthcare Devices and Services ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The analysts forecast ... market to grow at a CAGR of 30.42% ... covers the present scenario and the growth prospects ...
(Date:3/26/2015)... Md. , March 26, 2015  RegeneRx Biopharmaceuticals, ... it has received a patent acceptance notice from the ... 4 (TB4) to prevent or reduce tissue damage caused ... the case when cardiac vessels are opened after a ... when treating stroke victims. Damage can be ...
(Date:3/26/2015)...  Becton, Dickinson and Company (NYSE: BDX ) ... exchange all validly tendered and accepted notes of the ... subsidiary of BD, for notes to be issued by ... Statement on Form S-4 (the "Registration Statement") relating to ... the Securities and Exchange Commission ("SEC") on March 26, ...
Breaking Medicine Technology:Global Smart Wearable Healthcare Devices and Services Market 2015-2019 WITH Apple, At&T, Ee, Google, Samsung, Sprint, Telefonica & T-Mobile Dominating 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 2RegeneRx Receives Israeli Patent Acceptance Notice for the Use of TB4 To Prevent Tissue Damage Associated with Heart Attack and Stroke Treatments 3Becton, Dickinson and Company to Commence Exchange Offers 2Becton, Dickinson and Company to Commence Exchange Offers 3Becton, Dickinson and Company to Commence Exchange Offers 4Becton, Dickinson and Company to Commence Exchange Offers 5
... 7, 2011 Intellect Neurosciences, Inc. (OTCBB: ILNS) a ... and multiple licenses with major pharmaceutical companies covering products ... Dr. Daniel Chain, Ph.D., Chairman and CEO will be ... Dr. Chain will be discussing the state of the ...
... The U.S. Food and Drug Administration and the ... a "parallel review" pilot program for concurrent review of ... (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ) ... today, issued procedures for voluntary participation and guiding principles ...
Cached Medicine Technology:Intellect Neurosciences CEO to be Featured on Wall Street Reporter 2FDA, CMS Launch Pilot Program for Voluntary Parallel Review of Innovative Devices 2
(Date:3/26/2015)... Dr. Rod J. Rohrich, who served as ... and has trained over 6500 surgeons through these meetings ... medicine (EBM), that is, the optimization of decision making ... often hear from rhinoplasty surgeons who describe ... not trying to stifle these discussions, we do want ...
(Date:3/26/2015)... UC Davis will establish a prestigious, leading-edge center ... A Silvio O. Conte Center for Basic or Translational ... the United States. , The center will be funded ... of Mental Health, which will allow UC Davis’ Conte ... of schizophrenia may be dysregulation of immune molecules that ...
(Date:3/26/2015)... Scott Sullivan and Frank DellaCroce, Co-Founders of the ... St. Charles Surgical Hospital (SCSH) in New ... Oncologist Dr. William Karl Ordoyne has joined their highly ... oncologist Alan Stolier, M.D., FACS and the team of ... M.D., FACS; Chris Trahan, M.D., FACS; M. Whitten Wise, ...
(Date:3/26/2015)... (PRWEB) March 26, 2015 Building ... of continuing medical education, the Cardiometabolic Risk ... Medicine at Tulane University are proud to ... Medicine. The interdisciplinary program , which ... credential, is designed for physicians, nurse practitioners, physician ...
(Date:3/26/2015)... March 26, 2015 Visiting Nurse ... their 18th annual gala fundraiser, Lighting the Way, Brightening ... p.m. at The Madison Hotel in Morristown, NJ. ... entertainment by renowned musician Rio Clemente, delightful cuisine, an ... and Dave Hertzel. Additionally, two prestigious awards will be ...
Breaking Medicine News(10 mins):Health News:Dr. Rod Rohrich Explores Evidence Based Innovations and Safety at the 32nd Annual Dallas Rhinoplasty Symposium 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 2Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 3Health News:UC Davis Receives $10 Million Grant to Establish Center to Study Schizophrenia 4Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 2Health News:Surgical Oncologist Joins Center for Restorative Breast Surgery and St. Charles Surgical Hospital 3Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 2Health News:Certified Culinary Medicine Specialist Program Jointly Launched by Goldring Center for Culinary Medicine at Tulane University and Cardiometabolic Risk Summit 3Health News:Morristown VNA Fundraiser to Honor Distinguished Community Members 2
... Human ... , , ... (PRWEB) April 6, 2010 -- Human Touch , the U.S. market leader of innovative ... the World Federation of Chiropractic (WFC) for its massage chairs as a valid supplement to ...
... (short for sarcoma) is a family of proto-oncogenic tyrosine ... the most common malignant cancer in children. Src represents ... A recent study shows that pyrazolo-[3,4-d]pyrimidine-derivatives, designed to ... cell cycle and causing cancer cell death in medulloblastoma. ...
... Swedish medical university Karolinska Institutet provides evidence that basic ... that also exist in the most primitive vertebrates, such ... an investigation into the limbic striatum, one of the ... to learn movements, consciously and unconsciously, through repetition. ...
... ... massage. There are many other massages and spa services that customers can enjoy ... ... Envy’s New Jersey franchise group ( http://www.massageenvy.com/regions/NJ/Northern-New-Jersey.aspx ), a subsection of franchisees of ...
... and sedatives up 65 percent in U.S., study finds ... by accidental and intentional abuse of prescription sedatives, tranquilizers ... last decade, new research reveals. , Hospital stays from ... Percocet) and sedatives (such as Valium and Ativan) jumped ...
... ... ... Noni International (TNI) announced a new quarter of a million dollar challenge to all ... industry will measure up to Tahitian Noni Bioactive Beverages., , , , ,Tahitian Noni International ...
Cached Medicine News:Health News:Human Touch Massage Chairs Receive Exclusive Endorsement from World Federation of Chiropractic 2Health News:Human Touch Massage Chairs Receive Exclusive Endorsement from World Federation of Chiropractic 3Health News:Human Touch Massage Chairs Receive Exclusive Endorsement from World Federation of Chiropractic 4Health News:Human Touch Massage Chairs Receive Exclusive Endorsement from World Federation of Chiropractic 5Health News:New pyrimidine compounds may lead to improved treatments for childhood brain cancer 2Health News:Unconscious learning uses old parts of the brain 2Health News:Massage Envy New Jersey offers $49, 1-Hour Therapeutic Massage 2Health News:Prescription Drug Abuse Sending More to Hospitals 2Health News:Prescription Drug Abuse Sending More to Hospitals 3Health News:Quarter of a Million Dollar Superfruit Challenge Announced 2
Used as a percutaneous entry needle to introduce wire guides. The coaxial design reduces potential A.V. malformations. Supplied sterile in peel-open packages. Intended for one-time use....
Used under fluoroscopy for initial location and positioning of the renal collecting system throughout a percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
Used under fluoroscopy for initial location and positioning of the renal collecting system throughout a percutaneous nephrostomy. Supplied sterile in peel-open packages. Intended for one-time use....
The Linvatec 3mm and 5mm Universal Light Guides are autoclavable. They offer flexibility, superior light transmission, and universal fittings in a lightweight package....
Medicine Products: